I like the potential for the Hedgehog, but Cris sold of 90% of the Hh to Roche. Arias owns 100% of Ponatinib and 113. Each could potentially be a blockbuster (stress could potentially). Not many other bios can make that claim. That's been a common theme amongst some of the long term posters here for quite some time.
Just one of the reasons why I believe you would have to be out of your mind to think Ariad is a good short candidate.
Congrats to the maven. 1/2 of an 85% one day gain beats 0! ;0)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.